Inhaling device submitted for UK MHRA approval as nicotine replacement therapy

UK medical device manufacturer Ventus Medical has submitted a marketing authorisation application for an inhaling device to be used as a nicotine replacement therapy (NTR) in the UK.

The company’s submission to the UK Medicines and Healthcare Products Regulatory Agency (MHRA) was filed earlier this month for Enhale, a nicotine-based product the brand said can be used to quit both smoking and vaping.

Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*